Intrahepatic cholangiocarcinoma;Le cholangiocarcinome intra-hépatique

Journal de Chirurgie

Volumn 141, Issue 5, 2004, Pages 315-321

  Metairie S ^a,b   Lucidi, V ^a   Castaing, D ^a  

^a Centre Hépatobiliaire   (France)

^b HÔPITAL PAUL BROUSSE   (France)

Author keywords

Biliary tract; Cholangiocarcinoma; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

ASIA; BILE DUCT CARCINOMA; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CAROLI DISEASE; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; POPULATION RISK; RISK ASSESSMENT; SCLEROSING CHOLANGITIS; SHORT SURVEY;

EID: 7044231126     PISSN: 00217697     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0021-7697(04)95342-2     Document Type: Short Survey

References (34)

1. Liver Study Group of Japan. Classification of Primary Liver Cancer, 1st English edition, Tokyo, Kanehara, 1997;6-7.
2. Cholangiocarcinoma: Current Concepts and Insights. Gores GJ Hepatology 2003:37;961-969.
3. Su CH, Shyr YM, Lui WY, P'Eng FK. Hepatolithiasis associated with cholangiocarcinoma. Br J Surg 1997;84:969-973.
4. Chen MF, Jan YY, Wang CS, Hwang TL, Jeng LB, Chen SC, Chen TJ. A reappraisal of cholangiocarcinoma in patients with hepatolithiasis.Cancer 1993;71:2461-2465.
5. Jan YY, Chen MF, Wang CS, Jeng LB, Hwang TL, Chen SC. Surgical treatment of hepatolithiasis: long term results. Surgery 1996;120:509-514.
6. Lesurtel M, Regimbeau JM, Farges O, Colombat M, Sauvanet A, Belghiti J. Intrahepatic cholangiocarcinoma and hepatolithiasis: an unusual association in Western Coutries. Eur J Gastroenterology Hepatology 2002;14:1025-1027.
7. Lee CC, Wu CY, Chen GH. What is the impact of coexistence of hepatolithiasis on cholangiocarcinoma. J Gastroenterol Hepatol 2002;17:1015-1020.
8. Chen MF, Jan YY, Hwang TL, Jeng LB, Yeh TS. Impact of concomitant hepatolithiasis on patient with peripheral cholangiocarcinoma. Dig Dis Sci 2000;45:312-316.
9. Kawarada Y., Yamagiwa K., Das B.C. Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J surg 2002;183:679-685.
10. Pinyosophon A, Wiwanitkit V. The prevalence of hepatitis B seropositivity among patients with cholangiocarcinoma. Viral Immunol 2002;15:655-657.
11. Okuda K, Nakanuma Y, Miyazaki M. Cholangiocarcinoma: recent progress. Part 1: epidemiolgy and etiology. J Gastroenterol Hepatol 2002;17:1049-1055.
12. Okuda K, Nakanuma Y, Miyazaki M. Cholangiocarcinoma: recent progress. Part 2: molecular pathology and treatment. J Gastroenterol Hepatol 2002;17:1056-1063.
13. Bloom CM, Langer B, Wilson SR. Role of US in the detection, characterization, and staging of cholangiocarcinoma. Radiographics 1999;19:1999-218.
14. Tillich M, Mishchinger HJ, Preisegger KH, Rabl H, Szolar DH. Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma. Am J Roentgenol 1998;171:651-658.
15. Ohtsuka M., Ito H., Kimura F., Shimizu H., Togawa A., Yoshidome H., Miyazaki M. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 2002;89:1525-1531.
16. Uenishi T., Hirohashi K., Kubo S., Yamamoto T., Yamazaki O., Kinoshita H. Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma. Br J Surg 2001;88:969-974.
17. Weber S.M., Jarnagin W.R., Klimstra D., DeMatteo R.P., Fong Y., Blumgart L.H. Intrahepatic Cholangiocarcinoma: Recurrence Pattern, and Outcomes. Am Coll Surg 2001;193:384-391.
18. Isa T, Kusano T, Shimoji H, Takeshima Y, Muto Y, Furukawa M. Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma. Am J Surg 2001;181:507-511.
19. Nakagohri T, Asano T, Kinoshita H, Kenmochi T, Urashima T, Miura F, et al. Aggresive surgical resection for hilar invasive and peripheral intrahepatic cholangiocarcinoma. World J Surg 2003;27:289-293.
20. Kuhn R, Hribaschek A, Eichelmann K, Rudolph S, Fahlke J, Ridwelski K. Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio-carcinomas. Invest New Drugs 2002;20:351-356.
21. Gallardo J, Cabrera e, Rubio B, Gonzalez C, Cortes C. Gemcitabine in the treatment of 4 patients with cholangiocarcinoma. Rev Med Chil 2001;129:911-916.
22. Serafini FM, Sachs D, Bloomston M, Carey LC, Karl RC, Murr MM, et al. Location, not staging, of cholangiocarcinoma determines the role for adjuvant chemoradiation therapy. Am Surg 2001;67:843-844.
23. Fujii Y, Shimada H, Endo I, Morioka D, Nagano Y, Miura Y, et al. Effect of portal vein embolization before major hepatectomy. Hepatogastrenterology 2003;56:39-44.
24. Yamanaka N, Dai CL, Okamoto E. Historical evolution of hypothermic liver surgery. World J Surg 1998;22:1104-1107.
25. Ohya T, Ohwada S, Morishita Y. Does hypothermic perfusion have beneficial effects for ischemic liver during extended hepatectomy with hepatic inflow occlusion of canine liver? A comparative study with topical cooling. Hepatogastroenterology 1998;45:477-482.
26. Roayaie S, Guarrera JV, Ye MQ, Thung SN, Emre S, Fishbein TM, et al. Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg 1998;187:365-72
27. Lieser MJ, Barry MK, Rowland C, Ilstrup DM, Nagorney DM. Surgical mangement of intrahepatic cholangiocarcinoma: a 33 years experience. J Hepatobiliary Pancreat Surg. 1998;5:44-7
28. Isaji S, Kawarada Y, Taoka H, Tabata M, Suzuki H, Yokoi H. Clinicopathotological features and outcome of hepatic resection for intrahepatic cholangiocarcinma in Japan. J Hepatobiliary Pancreat Surg.1999;6:108-116.
29. El Rassi ZE, Partensky C, Scoazec JY, Henry L, Lombard-Boas C, Maddern G. Pheripheral cholangiocarcinoma: presentation, diagnosis, pathology and management. Eur J Surg Oncol 1999;25:375-380.
30. Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 2000;69:1633-1637.
31. Shimoda M, Farmer DG, Colquhoun SD, Rosove M, Ghobrial RM, Yersiz H, et al. Liver transplantation for cholangiocellular carcinoma: analysis of a single center experience and review of the literature. Liver Transplant 2001;7:1023-1033.
32. Gores GJ. Early detection and treatment of cholangiocarcinoma. Liver transplant. 2000;6:30-34.
33. Keiding S, Hansen SB, Rasmussen HH, Gee A, Kruse A, Roelsgaard K, et al. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology 1998;28:700-706.
34. Benhamou JP, Menu Y. Lésions kystiques non parasitaires du foie et des voies biliaires intrahépatiques. In: Benhamou JP, Bircher J, Mc Intyre N, Rizzetto M, Rodès J. Hépatologie clinique. Paris. Flammarion Médecine-Sciences, 1993, 520-525.